Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma

Aurora A Kinase (AURKA), a member of the serine/threonine kinase family, plays a critical role in cell division, and it is widely overexpressed in a variety of tumors including glioblastoma (GBM). Alisertib (MLN8237) is an orally administered selective AURKA inhibitor with potent antiproliferative a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurooncol
Main Authors: Kurokawa, C, Geekiyanage, H, Allen, C, Iankov, I, Schroeder, M, Carlson, B, Bakken, K, Sarkaria, J, Ecsedy, JA, D’Assoro, A, Friday, B, Galanis, E
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5263047/
https://ncbi.nlm.nih.gov/pubmed/27816996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-016-2285-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados